InsidersTradesSigma
Follow the 레메디 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). The latest transaction was disclosed on 16 July 2026 (Purchase). Among the most active insiders: 조봉호. The full history is accessible without an account.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
레메디 es una empresa que cotiza en el mercado XKRX. Se especializa en el sector de la salud y la biotecnología.